Abstract |
MuStDO 5 is a multivalent plasmid DNA vaccine for malaria comprised of five plasmid DNAs encoding five proteins from Plasmodium falciparum and one plasmid DNA encoding human GM-CSF. To evaluate the safety of MuStDO 5, a series of pre-clinical studies were conducted in mice and rabbits. In pharmacology studies in mice, GM-CSF could not be detected in the serum following either intramuscular or a combined intramuscular/intradermal administration of the vaccine, but was readily detected in the muscle following intramuscular administration. In a tissue distribution study in mice, MuStDO 5 plasmid DNA was detected by PCR initially in highly vascularized tissues, while at later time-points the plasmid DNA was detected primarily at the site(s) of injection. In GLP safety studies in mice and rabbits, repeated intramuscular/intradermal administration of the MuStDO 5 vaccine was found to be safe and well tolerated without any evidence of autoimmune pathology.
|
Authors | S E Parker, D Monteith, H Horton, R Hof, P Hernandez, A Vilalta, J Hartikka, P Hobart, C E Bentley, A Chang, R Hedstrom, W O Rogers, S Kumar, S L Hoffman, J A Norman |
Journal | Gene therapy
(Gene Ther)
Vol. 8
Issue 13
Pg. 1011-23
(Jul 2001)
ISSN: 0969-7128 [Print] England |
PMID | 11438836
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Adjuvants, Immunologic
- Antibodies, Antinuclear
- Malaria Vaccines
- Vaccines, DNA
- Granulocyte-Macrophage Colony-Stimulating Factor
|
Topics |
- Adjuvants, Immunologic
(pharmacokinetics, toxicity)
- Animals
- Antibodies, Antinuclear
(blood)
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
(genetics, pharmacokinetics, toxicity)
- Injections, Intradermal
- Injections, Intramuscular
- Malaria Vaccines
(immunology, pharmacokinetics, toxicity)
- Male
- Mice
- Mice, Inbred Strains
- Muscle, Skeletal
(metabolism)
- Plasmids
- Polymerase Chain Reaction
- Rabbits
- Tissue Distribution
- Vaccines, DNA
(immunology, pharmacokinetics, toxicity)
|